Atlas Trials

A Phase1 Study of VIB9600

Clinical trial NCT03621605 · TERMINATED

Trial details

NCT number
NCT03621605
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Safety Issues
Start date
2018-08-14
Primary completion
2019-04-08
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.